Cargando…

Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain

BACKGROUND: [(11)C]Cimbi-36 is a serotonin 2A receptor agonist positron emission tomography radioligand that has recently been examined in humans. The binding of agonist radioligand is expected to be more sensitive to endogenous neurotransmitter concentrations than antagonist radioligands. In the cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kai-Chun, Stepanov, Vladimir, Martinsson, Stefan, Ettrup, Anders, Takano, Akihiro, Knudsen, Gitte M, Halldin, Christer, Farde, Lars, Finnema, Sjoerd J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581490/
https://www.ncbi.nlm.nih.gov/pubmed/28911007
http://dx.doi.org/10.1093/ijnp/pyx051
_version_ 1783261060338286592
author Yang, Kai-Chun
Stepanov, Vladimir
Martinsson, Stefan
Ettrup, Anders
Takano, Akihiro
Knudsen, Gitte M
Halldin, Christer
Farde, Lars
Finnema, Sjoerd J
author_facet Yang, Kai-Chun
Stepanov, Vladimir
Martinsson, Stefan
Ettrup, Anders
Takano, Akihiro
Knudsen, Gitte M
Halldin, Christer
Farde, Lars
Finnema, Sjoerd J
author_sort Yang, Kai-Chun
collection PubMed
description BACKGROUND: [(11)C]Cimbi-36 is a serotonin 2A receptor agonist positron emission tomography radioligand that has recently been examined in humans. The binding of agonist radioligand is expected to be more sensitive to endogenous neurotransmitter concentrations than antagonist radioligands. In the current study, we compared the effect of serotonin releaser fenfluramine on the binding of [(11)C]Cimbi-36, [(11)C]MDL 100907 (a serotonin 2A receptor antagonist radioligand), and [(11)C]AZ10419369 (a serotonin 1B receptor partial agonist radioligand with established serotonin sensitivity) in the monkey brain. METHODS: Eighteen positron emission tomography measurements, 6 for each radioligand, were performed in 3 rhesus monkeys before or after administration of 5.0 mg/kg fenfluramine. Binding potential values were determined with the simplified reference tissue model using cerebellum as the reference region. RESULTS: Fenfluramine significantly decreased [(11)C]Cimbi-36 (26–62%) and [(11)C]AZ10419369 (35–58%) binding potential values in most regions (P < 0.05). Fenfluramine-induced decreases in [(11)C]MDL 100907 binding potential were 8% to 30% and statistically significant in 3 regions. Decreases in [(11)C]Cimbi-36 binding potential were larger than for [(11)C]AZ10419369 in neocortical and limbic regions (~35%) but smaller in striatum and thalamus (~40%). Decreases in [(11)C]Cimbi-36 binding potential were 0.9 to 2.8 times larger than for [(11)C]MDL 100907, and the fraction of serotonin 2A receptor in the high-affinity state was estimated as 54% in the neocortex. CONCLUSIONS: The serotonin sensitivity of serotonin 2A receptor agonist radioligand [(11)C]Cimbi-36 was higher than for antagonist radioligand [(11)C]MDL 100907. The serotonin sensitivity of [(11)C]Cimbi-36 was similar to [(11)C]AZ10419369, which is one of the most sensitive radioligands. [(11)C]Cimbi-36 is a promising radioligand to examine serotonin release in the primate brain.
format Online
Article
Text
id pubmed-5581490
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-55814902017-09-06 Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain Yang, Kai-Chun Stepanov, Vladimir Martinsson, Stefan Ettrup, Anders Takano, Akihiro Knudsen, Gitte M Halldin, Christer Farde, Lars Finnema, Sjoerd J Int J Neuropsychopharmacol Regular Research Article BACKGROUND: [(11)C]Cimbi-36 is a serotonin 2A receptor agonist positron emission tomography radioligand that has recently been examined in humans. The binding of agonist radioligand is expected to be more sensitive to endogenous neurotransmitter concentrations than antagonist radioligands. In the current study, we compared the effect of serotonin releaser fenfluramine on the binding of [(11)C]Cimbi-36, [(11)C]MDL 100907 (a serotonin 2A receptor antagonist radioligand), and [(11)C]AZ10419369 (a serotonin 1B receptor partial agonist radioligand with established serotonin sensitivity) in the monkey brain. METHODS: Eighteen positron emission tomography measurements, 6 for each radioligand, were performed in 3 rhesus monkeys before or after administration of 5.0 mg/kg fenfluramine. Binding potential values were determined with the simplified reference tissue model using cerebellum as the reference region. RESULTS: Fenfluramine significantly decreased [(11)C]Cimbi-36 (26–62%) and [(11)C]AZ10419369 (35–58%) binding potential values in most regions (P < 0.05). Fenfluramine-induced decreases in [(11)C]MDL 100907 binding potential were 8% to 30% and statistically significant in 3 regions. Decreases in [(11)C]Cimbi-36 binding potential were larger than for [(11)C]AZ10419369 in neocortical and limbic regions (~35%) but smaller in striatum and thalamus (~40%). Decreases in [(11)C]Cimbi-36 binding potential were 0.9 to 2.8 times larger than for [(11)C]MDL 100907, and the fraction of serotonin 2A receptor in the high-affinity state was estimated as 54% in the neocortex. CONCLUSIONS: The serotonin sensitivity of serotonin 2A receptor agonist radioligand [(11)C]Cimbi-36 was higher than for antagonist radioligand [(11)C]MDL 100907. The serotonin sensitivity of [(11)C]Cimbi-36 was similar to [(11)C]AZ10419369, which is one of the most sensitive radioligands. [(11)C]Cimbi-36 is a promising radioligand to examine serotonin release in the primate brain. Oxford University Press 2017-06-20 /pmc/articles/PMC5581490/ /pubmed/28911007 http://dx.doi.org/10.1093/ijnp/pyx051 Text en © The Author 2017. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Regular Research Article
Yang, Kai-Chun
Stepanov, Vladimir
Martinsson, Stefan
Ettrup, Anders
Takano, Akihiro
Knudsen, Gitte M
Halldin, Christer
Farde, Lars
Finnema, Sjoerd J
Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain
title Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain
title_full Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain
title_fullStr Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain
title_full_unstemmed Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain
title_short Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain
title_sort fenfluramine reduces [(11)c]cimbi-36 binding to the 5-ht(2a) receptor in the nonhuman primate brain
topic Regular Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581490/
https://www.ncbi.nlm.nih.gov/pubmed/28911007
http://dx.doi.org/10.1093/ijnp/pyx051
work_keys_str_mv AT yangkaichun fenfluraminereduces11ccimbi36bindingtothe5ht2areceptorinthenonhumanprimatebrain
AT stepanovvladimir fenfluraminereduces11ccimbi36bindingtothe5ht2areceptorinthenonhumanprimatebrain
AT martinssonstefan fenfluraminereduces11ccimbi36bindingtothe5ht2areceptorinthenonhumanprimatebrain
AT ettrupanders fenfluraminereduces11ccimbi36bindingtothe5ht2areceptorinthenonhumanprimatebrain
AT takanoakihiro fenfluraminereduces11ccimbi36bindingtothe5ht2areceptorinthenonhumanprimatebrain
AT knudsengittem fenfluraminereduces11ccimbi36bindingtothe5ht2areceptorinthenonhumanprimatebrain
AT halldinchrister fenfluraminereduces11ccimbi36bindingtothe5ht2areceptorinthenonhumanprimatebrain
AT fardelars fenfluraminereduces11ccimbi36bindingtothe5ht2areceptorinthenonhumanprimatebrain
AT finnemasjoerdj fenfluraminereduces11ccimbi36bindingtothe5ht2areceptorinthenonhumanprimatebrain